Cash & equivalents increased 76.0%
Cash & equivalents changed +76.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +76.0% from the comparable as-filed period.
Gross margin changed +535 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross profit changed +22.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +205.2% from the comparable as-filed period.
Operating income changed +268.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +708 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed -16.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory changed -5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Revenue changed +2.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed -1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.